February 5, 2008 – CV Therapeutics Inc. and Medlogics Device Corp. entered into an agreement under which Medlogics has licensed CV Therapeutics’ proprietary biopolymer stent coating technology to develop a drug eluting stent (DES), as Medlogics recently received CE Mark for its Cobalt Super Alloy (COBRA) stent.

CV Therapeutics received Medlogics stock and is entitled to development milestone payments, royalties and other potential payments on future sales of any products incorporating the technology.

The Sentinel by Spacelabs reportedly integrates an entire range of noninvasive diagnostic cardiology solutions including: ECG exercise testing, 12-Lead ECG, holter monitoring, ECG event recording and ambulatory blood pressure monitoring into one central data management system.

The system reportedly centralizes all solutions in a central networked database that reduces the need for paper records.

The latest version of GE’s MUSE 7.0 system reportedly incorporates enhancements in information technology, ECG management processes and clinical report editing in an all-digital environment for paperless workflow.

The HeartStation ECG management system automates the processing and storage of electrocardiograms to reportedly improve timely access to ECG exams throughout the secure hospital network.

Medtronic Inc. received FDA clearance of the Reveal DX Insertable Cardiac Monitor (ICM) designed to help physicians identify the cause of unexplained fainting or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.

CardioDynamics recently received market clearance from the FDA for its BioZ Impedance Cardiography (ICG) clinical parameters and electronic medical record (EMR) interface capability for its BioZ Dx System.

A new 320-slice computed tomography (CT) system, the AquilionONE by Toshiba America Medical Systems, delivers dynamic volume imaging that can image an entire organ in a single rotation or over multiple rotations, showing real-time dynamic movement.
Multiphase studies, such as perfusion of the brain, heart and other organs, are also possible with the new system.

February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.

February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer Analyzer, which are designed to be rugged, portable test instrumentation for biomedical technical professionals to ensure proper operation and ultimate performance of critical life-support cardiac resuscitati

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now